Texas Top Legal Officer Sues Acetaminophen Producers Regarding Autism Claims

Judicial Proceedings
Ken Paxton, who supports former President Trump seeking election to the United States Senate, claimed pharmaceutical manufacturers of concealing safety concerns of Tylenol

The top legal official in Texas Ken Paxton is suing the producers of Tylenol, claiming the firms withheld alleged dangers that the pain reliever created to children's brain development.

The court filing arrives four weeks after Donald Trump publicized an unproven link between taking acetaminophen - alternatively called acetaminophen - during pregnancy and autism in offspring.

Paxton is suing the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever recommended for pregnant women, and the current manufacturer, which currently produces it.

In a statement, he claimed they "misled consumers by gaining financially from pain and promoting medication ignoring the potential hazards."

The manufacturer says there is no credible evidence tying Tylenol to autism.

"These corporations deceived for years, deliberately risking numerous people to line their pockets," Paxton, a Republican, said.

The manufacturer stated officially that it was "seriously troubled by the dissemination of inaccurate information on the security of paracetamol and the possible consequences that could have on the welfare of women and children in America."

On its online platform, the company also stated it had "continuously evaluated the pertinent research and there is no credible data that shows a established connection between taking acetaminophen and autism."

Associations speaking for physicians and medical practitioners agree.

ACOG has declared paracetamol - the key substance in Tylenol - is among limited choices for women during pregnancy to manage discomfort and fever, which can pose significant medical dangers if left untreated.

"In multiple decades of studies on the utilization of paracetamol in gestation, zero credible investigations has definitively established that the consumption of paracetamol in any period of pregnancy leads to neurodevelopmental disorders in offspring," the organization commented.

The lawsuit mentions current declarations from the previous government in asserting the drug is reportedly hazardous.

In recent weeks, Trump caused concern from health experts when he instructed expectant mothers to "resist strongly" not to take acetaminophen when sick.

The FDA then released a statement that doctors should consider limiting the consumption of Tylenol, while also stating that "a proven link" between the medication and autism spectrum disorder in children has remains unverified.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had promised in April to initiate "a massive testing and research effort" that would determine the origin of autism spectrum disorder in a short period.

But authorities cautioned that identifying a unique factor of autism spectrum disorder - thought by researchers to be the result of a complex mix of inherited and external influences - would be difficult.

Autism is a type of permanent neurological difference and impairment that influences how individuals experience and relate to the surroundings, and is diagnosed using medical professional evaluations.

In his court filing, Paxton - aligned with the former president who is seeking US Senate - alleges Kenvue and J&J "deliberately disregarded and sought to suppress the research" around acetaminophen and autism.

The case aims to force the firms "destroy any promotional materials" that states acetaminophen is secure for women during pregnancy.

The Texas lawsuit parallels the complaints of a group of mothers and fathers of minors with autism and ADHD who took legal action against the producers of Tylenol in 2022.

A federal judge rejected the legal action, declaring research from the plaintiffs' authorities was not conclusive.

Jason Myers
Jason Myers

A passionate storyteller and digital creator, sharing unique narratives and life experiences to inspire readers worldwide.